Recent work has demonstrated care fragmentation (CF), such as readmission to hospitals that did not perform the surgery (non-index), may result in worse patient outcomes. Our objective was to analyze trends in readmission and CF rates following major urologic oncology surgeries to better understand the burden of CF in urologic oncology and characterize recent trends over time.
INTRODUCTION AND OBJECTIVES:
Recent work has demonstrated care fragmentation (CF), such as readmission to hospitals that did not perform the surgery (non-index), may result in worse patient outcomes. Our objective was to analyze trends in readmission and CF rates following major urologic oncology surgeries to better understand the burden of CF in urologic oncology and characterize recent trends over time.
METHODS: Patients who underwent cystectomy (RC), prostatectomy (RP), nephrectomy (RN), partial nephrectomy (PN), nephroureterectomy (NU), and retroperitoneal lymph node dissection (RPLND) were identified in the 2010-2014 Nationwide Readmissions Database. Among readmitted patients, CF was defined as a readmission to a nonindex hospital in 90-day follow-up after surgery. Ninety-day readmission and CF rates were compared across time within each procedure using univariable and multivariable logistic regression.
RESULTS: Overall, 90-day readmission rates were (Figure) 40.3% for RC (n[9,964), 5.8% for RP (n[12, 341), 14.9% for RN (n[11, 542), 14.0% for PN (n[6, 419), 17.6% for NU (n[2, 431), and 18.1% for RPLND (n[321) . In multivariable models controlling for: x y z, PN was the only surgery with a significant decrease in 90-day readmission rates over time (OR[0.94 per year, ptrend[0.002) . Among readmitted patients, 90-day CF rates were 33.3% for RC, 32.1% for RP, 32.0% for RN, 28.1% for PN, 33.0% for NU, and 26.2% for RPLND. In multivariable models, 90-day CF rates did not significantly change over time for any of the surgeries (all p>0.05).
CONCLUSIONS: This is the first study to investigate trends in nationally representative estimates of readmission and CF rates following major urologic oncology surgeries. PN was the only procedure with improved readmission rates over time. For all other procedures studied, readmission and CF rates have not improved over recent years. There was no single predictor of 90-day readmission or CF that was consistent across all surgeries, highlighting each surgery likely requires an individualized approach to improve readmission rates. Furthermore, since CF rates have been consistent in recent years, future efforts should focus on better understanding the impact of CF on patient outcomes following major urologic oncology surgeries.
Source of Funding: None

MP29-18 PHARMACEUTICAL PAYMENTS FOR OPIOIDS SIGNIFICANTLY FAVOR EXTENDED-RELEASE MEDICATION AND CORRELATE WITH PHYSICIAN PRESCRIPTIONS
Austin Lee, Omar Ayyash*, Avinash Maganty, Liam Macleod, Jathin Bandari, Bruce Jacobs, Benjamin Davies, Pittsburgh, PA INTRODUCTION AND OBJECTIVES: Extended release opioid formulations were formulated as a means of hopefully reducing abuse and dependence. Still the vast majority of opioid prescriptions written remain immediate-release. We therefore sought to investigate the influence of industry payments to physicians on extended release opioid prescriptions.
METHODS: We utilized the 2014 and 2015 Centers for Medicare & Medicaid (CMS) Open Payments database to identify industryrelated payments to physicians for opioids. These payments were linked to physician prescriptions through claims from the corresponding Medicare Part D Opioid Prescriber Summary File database. We categorized 21 unique opioids into either extended or immediate release.
RESULTS: We identified 14 companies marketing 10 extended release formulations. The top paying company was Purdue Pharma who spent over $13 million in payments to physicians. Purdue also markets more opioids than any other company (12 products) as well as the opioid with the largest contribution to payments (Oxycontin at $5.3 million). The median payment for extended release formulations was more than twice as high as for immediate release ($100 vs $37, p < 0.001). Among those receiving payments, there was a statistically significant correlation between increasing payments and opioid prescriptions. This was true for both immediate release (rho [ 0.18, p < 0.001) and extended release (rho [ 0.25, p < 0.001) [ Figure] .
CONCLUSIONS: There appears to be an effort to increase physician payments for Extended-Release Opioids. This is likely because these drugs are less prone to abuse and potentially helpful in addiction treatment.
Source of Funding: Bruce L. Jacobs is supported in part by the American Urological Association Data Grant and the University of Pittsburgh Physicians Foundation. The views expressed in this abstract do not reflect the views of the Federal government or Ben Davies.
MP29-19
CHASING THE PACK: ASSOCIATION BETWEEN UROLOGY HOSPITAL RANKINGS AND SURGICAL OUTCOME Alejandro Abello*, Jamil Syed, Michael Leapman, Patrick A. Kenney, New Haven, CT INTRODUCTION AND OBJECTIVES: Patients value hospital rankings when making decisions about their healthcare. Rankings, such as the US News and World Report (USNWR) integrate safety, outcome, and reputation metrics, however it is unknown whether these rankings are robust to surgery type, or if meaningful differences exist within top performing strata. Therefore, we aimed to study the associations of USNWR ranking and outcome measures using national registry data.
METHODS: We used the Vizient CDB a hospital registry representing care at 97% of academic centers to analyze outcomes for urologic surgeries from 2014 through 2018. We compiled the following hospital outcomes on mortality, length of stay (LOS), 30-day readmissions, LOS index (observed/expected ratios), case mix index and patient safety and adverse event composite (PSI-90) for radical prostatectomy (RP), cystectomy (RC) and radical nephrectomy (RN). We studied the associations of USNWR "Top 50 Hospitals" and outcome by surgery type and in aggregate.
RESULTS: We identified 20,888 cases including 8,385 RP, 7,486 RN and 5,017 RC during the study period. Case volume was significantly higher in top 10 hospitals for RP, RC, and RN compared to 11-20 that was the second group with highest volume (1,700 more cases for RP, 1,806 for RN and 490 for RC; P <0.001). Hospital LOS was significantly lower in the upper quintile for RP (P <0.001) and RN (P<0.001) but not in RC. Adjusting for expected ratios, LOS index was similar in RP among the different quintiles but was lower for RN. 30-day readmission in upper quintile was significantly lower in RP only compared to 41-50 but similar to 11-40 institutions There was not significant variation in mortality between groups or procedures. Bottom ranking positions were negatively correlated with surgical volume (RP rho: -0.50, P<0.001; RN rho -0.41, P 0.005; RC rho: -0.42, P 0.0013) and positively correlated with mean LOS for RP (rho 0.45, P 0.002) and RC (rho 0.48, P 0.001). No other significant differences were found for the other variables. Comparing outcomes individually by hospitals, no significant differences or trends were found favoring top hospitals for LOS, mortality, costs, readmissions or PSI-90.
CONCLUSIONS: USNWR ranking of top urology programs was associated with better measures of patient outcome including mortality, readmission, and length of stay when grouped by quintiles and remained consistent across major cancer surgery types. There were no significant differences in outcome within deciles of rank, suggesting that categories of performance rather than ordinal position may be sufficient to describe hospital quality.
Source of Funding: None
MP29-20 EPIDEMIOLOGY OF GENITOURINARY FOREIGN BODIES IN THE UNITED STATES EMERGENCY ROOM SETTING AND ITS ASSOCIATION WITH MENTAL HEALTH DISORDERS
INTRODUCTION AND OBJECTIVES:
The epidemiology of genito-urinary foreign bodies (GUFB) has been mainly reported through case reports and small series. The aim of this study is to investigate the epidemiology, the medical-socio-economic factors associated with GUFB and the cost in the United States emergency room setting.
METHODS: Emergency Department (ED) visits with the primary diagnosis of a genito-urinary foreign body (based on ICD-9 codes 939.0-939.9) between 2010-2014 were abstracted from the Nationwide Emergency Department Sample database.
RESULTS: Between 2010 and 2014, a weighted estimate of 120,223 visits to the ED with GUFB were recorded in the US, representing a national incidence of 7.6 ED visits per 100,000 persons. 4.68% of ED visits resulted in admissions and males were more likely to be admitted (24.8% vs 2.1%, p < 0.01). A third of patients had low income, 30% had no medical insurance, and a third of patients had Medicaid. Urethra/bladder and penile foreign bodies had a significant association with mental health disorders when compared to vulvar/ vaginal foreign bodies (35.6% vs. 6.1%, p < 0.001). Costs of managing patients in the ED averaged $3,769. More importantly, penile or urethra/ bladder foreign bodies incurred a higher cost ($30,071) .
CONCLUSIONS: This is the largest population-based study investigating the epidemiology of genito-urinary foreign bodies, which occurs at a higher incidence than expected. GUFB are more common in young women and the majority of them are vulvar/vaginal. Penile and urethral/bladder foreign bodies occurred in older male patients and are associated with longer hospital stays and costs. Mental health disorders were more common in male patients and in cases of urethral/bladder foreign bodies.
